Kathie M. Bishop

Bishop is senior vice president, chief scientific officer and head of rare disease at Acadia Pharmaceuticals. She was chief scientific officer at LocanaBio, responsible for research and development for RNA-target gene therapies for neurodegenerative and ocular diseases.

  • October 2022

Added to: DTx Pharma Inc. - San Diego, CA

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.